Quick Takeaways: Why It Matters? The Texas A&M study positions Pictor’s PictVet assay as a highly accurate, non‑invasive tool for monitoring Mycoplasma bovis–associated immune responses in beef cattle, supporting broader use of targeted proteomics in her...
Quick Takeaways Why It Matters? Piclidenoson could open a new, higher‑value segment in the canine osteoarthritis market as one of the first oral, potentially disease‑modifying options rather than just another pain reliever. If the ongoing Phase II trial confirms the posit...
Quick Takeaways: Why It Matters? Data for LPT‑CBD strengthens the scientific case for long‑acting, injectable CBD as a legitimate chronic pain option, not just a wellness supplement, which can increase veterinarian openness to cannabinoid-based therapies. The sustaine...
